Gut microbiota and immune mediation: a Mendelian randomization study on granulomatosis with polyangiitis

Yizhen Chen1, Shilin Tang1

  • 1Department of Cardiology, Affliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou, China.

Frontiers in Immunology
|December 13, 2023
PubMed
Abstract

Insights

This study explored the gut microbiota

Area of Science:

  • Microbiology
  • Immunology
  • Genetics

Background:

  • The gut microbiota significantly impacts health, including immune conditions.
  • Granulomatosis with Polyangiitis (GPA) is an immune-mediated disease with potential, yet underexplored, links to gut bacteria.

Purpose of the Study:

  • To investigate causal relationships between gut microbiota and Granulomatosis with Polyangiitis (GPA).
  • To explore mediation effects of immune traits in the gut microbiota-GPA axis.

Main Methods:

  • Employed a two-sample Mendelian randomization approach.
  • Utilized data from multiple cohorts and consortiums, including MiBioGen.
  • Examined direct associations and immune-mediated effects.

Main Results:

  • Identified significant associations between specific gut microbiota taxa (1 phylum, 1 family, 9 genera) and GPA.
  • Found immune cell traits mediating the gut microbiota-GPA link, e.g., Defluviitaleaceae family/genus influencing GPA via granulocyte CD11c.
  • Quantified mediation effect proportions to understand complex interactions.

Conclusions:

  • Established an intricate relationship between gut microbiota, immune markers, and GPA.
  • Highlighted potential therapeutic strategies targeting the gut microbiota for GPA management.

Related Concept Videos